Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial
Survival rates following risk stratification including M + ASCT are higher than historical observations for similar high-risk groups that did not include high-dose chemotherapy.
Authors
- D.J. Saunders (ORCID: https://orcid.org/0000-0003-0151-1155)
- Vesna Pavasovic
- Sucheta Vaidya (ORCID: https://orcid.org/0000-0003-2980-9316)
- Gordan Vujanić (ORCID: https://orcid.org/0000-0003-0726-6939)
- Rachel Hobson (ORCID: https://orcid.org/0000-0002-1535-6339)
- V. Moroz (ORCID: https://orcid.org/0000-0001-9748-1450)
- Juliet Hale
- Mark Powis
- Stephen Baker
- Patricia Sartori
- Kathy Pritchard‐Jones
Institutions
- University College Hospital (GB)
- Qatar Airways (Qatar) (QA)
- Royal Marsden NHS Foundation Trust (GB)
- Institute of Cancer Research (GB)
- University of Leicester (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Great Ormond Street Hospital (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- The Christie NHS Foundation Trust (GB)
- Cancer Research UK Clinical Trials Unit (GB)
- Weill Cornell Medical College in Qatar (QA)
- University College London (GB)
- University of Birmingham (GB)
- Newcastle University (GB)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2026-03-15
- DOI
- https://doi.org/10.1002/1545-5017.70191
- Primary Topic
- Renal and related cancers
- Type
- article
- Field-Weighted Citation Impact
- 0.00